Experience of brachytherapy using I-125 seed permanent implants for localized prostate cancer

Nippon Acta Radiologica

Volumn 65, Issue 4, 2005, Pages 432-437

  Toya, Kazuhito ^a   Yorozu, Atsunori ^a   Ohashi, Toshio ^a   Okada, Masahiro ^a   Itoh, Reiko ^a   Monma, Tetsuo ^a   Saito, Shiro ^a   Fukada, Junichi ^b   Sugawara, Akitomo ^b   Dokiya, Takushi ^c  

^a NATIONAL HOSPITAL ORGANIZATION TOKYO MEDICAL CENTER   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Brachytherapy; I 125 seed; Prostate cancer

Indexed keywords

RADIOACTIVE IODINE;

AGED; ARTICLE; BRACHYTHERAPY; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; PROSTATE; PROSTATE TUMOR; RADIOGRAPHY; RADIOMETRY;

AGED; AGED, 80 AND OVER; BRACHYTHERAPY; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; PROSTATE; PROSTATIC NEOPLASMS; RADIOMETRY; RADIOTHERAPY, COMPUTER-ASSISTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 28844435370     PISSN: 00480428     EISSN: 13477951     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Grimm PD, Blasko JC, Ragde H: Ultrasound-guided transperineal implantation of iodine-125 and palladium-103 for the treatment of early-stage prostate cancer. Atlas of the Urol Clin North Am 2(2): 113-125, 1994
2. Stock RG, Stone NN, Iannuzzi C: Sexual potency following interactive ultrasound-guided brachytherapy for prostate cancer. Int J Radial Oncol Biol Phys 35: 267-272, 1996
3. Whitmore WF Jr, Hilaris B, Gabstald H, et al: Retropubic implantation of iodine 125 in the treatment of prostatic cancer. J Urol 108: 918-920, 1972
4. Holm HH, Juul N, Pedersen JF, et al: Transperineal 125-iodine seed implantation in prostatic cancer guided by transrectal ultrasonography. J Urol 130: 283-286, 1983
5. Fagundes HM, Keys RJ, Wojcik MF, et al: Transperineal TRUS-guided prostate brachytherapy using loose seeds versus RAPIDStrand: a dosimetric analysis. Brachytherapy 3: 136-140, 2004
6. Willins J, Wallner K: CT-based dosimetry for transperineal I-125 prostate brachyherapy. Int J Radiat Oncol Biol Phys 39: 347-353, 1997
7. Stock RG, Stone NN, Wesson MF, et al: A modified technique allowing interactive ultrasound-guided three-dimensional transperineal prostate implantation. Int J Radiat Oncol Biol Phys 32: 219-225, 1995
8. Shanahan TG, Nanavati PJ, Mueller PW, et al: A comparison of permanent prostate brachytherapy technique: preplan vs. hybrid interactive planning with postimplant analysis. Int J Radiat Oncol Biol Phys 53: 490-496, 2002
9. Wallner K, Roy J, Harrison L: Dosimetry guidelines to minimize urethral and rectal morbidity following transperineal I-125 prostate brachytherapy. Int J Radiat Oncol Biol Phys 32: 465-471, 1995
10. Waterman FM, Dicker AP: Determination of the urethral dose in prostate brachytherapy when the urethra cannot be visualized in the postimplant CT scan. Med Phys 27: 448-451, 2000
11. Waterman FM, Dicker AP: Is it necessary to eliminate the posterior dose margin in prostate brachytherapy to achieve an acceptably low risk of late rectal morbidity? Int J Radiati Oncol Biol Phys 57: 293-299, 2003
12. 125I prostate brachytherapy. Int J Radiat Oncol Biol Phys 55: 342-353, 2003
13. Han B, Wallner K: Dosimtric and radiographic correlates to prostate brachytherapy-related rectal complications. (submitted) 2002